Profund Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$165K Sell
11,043
-3,619
-25% -$54.2K 0.01% 932
2025
Q1
$237K Sell
14,662
-200
-1% -$3.23K 0.01% 820
2024
Q4
$346K Buy
14,862
+787
+6% +$18.3K 0.01% 694
2024
Q3
$414K Buy
14,075
+1,469
+12% +$43.2K 0.02% 616
2024
Q2
$296K Buy
+12,606
New +$296K 0.01% 725